EUVIMEDEUVIMED entdecken
Crossref

Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia

Erin C Ho iD, Kaitlin E Olson, Molly Butler, Meghan Birkholz, Kristen Miller, Christine E MacBrayne, Sarah Jung, Kevin Messacar, Edwin J Asturias, Samuel R Dominguez

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae439 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Erin C Ho und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA. Hauptthemen laut MEDLINE: Streptococcus pneumoniae, Polymerase Chain Reaction, Pleural Effusion, Anti-Bacterial Agents. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Pediatric Infectious Diseases Society, Stanley and Susan Plotkin and, Sanofi Pasteur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While Streptococcus pneumoniae (Spn) is the leading cause of pediatric complicated community-acquired pneumonia (cCAP), it is infrequently recovered by culture-based methods. We studied the real-world clinical impact of an Spn polymerase chain reaction (PCR) assay for pleural fluid.

Methods

This pre–post quasi-experimental cohort study compared pathogen detection, antibiotic usage, and outcomes in children hospitalized with cCAP requiring pleural effusion or empyema drainage at Children's Hospital Colorado between 2016 and 2023. Patients were compared across 2 diagnostic periods: pre-Spn PCR and post-Spn PCR. Cox proportional hazard models compared time from admission to pathogen detection, optimal therapy (narrowest pathogen-directed or guideline-recommended empiric therapy), and methicillin-resistant Staphylococcus aureus (MRSA) therapy discontinuation between periods.

Results

Compared to the pre-Spn PCR cohort (n = 149), the post-Spn PCR cohort (n = 79) was more likely to have a pathogen detected (73.4% post-PCR vs 38.9% pre-PCR, P < .001), driven by more Spn detections (45.6% vs 14.1%, P < .001). Time to pathogen detection during hospitalization was shorter in the post-Spn PCR period (P < .001). The post-PCR cohort was more likely to receive optimal therapy (84.8% vs 53.0%, P < .001), with shorter median times to optimal antibiotics (4.9 vs 10.0 days, P < .001) and MRSA therapy discontinuation (1.5 vs 2.5 days, P = .03). There were no differences in hospital length of stay or readmissions.

Conclusions

Spn molecular testing of pleural fluid in children with cCAP resulted in significantly more microbiologic diagnoses and was associated with the optimization of antibiotics and decreased exposure to MRSA therapy, suggesting its clinical impact for pediatric complicated pneumonia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus pneumoniaePolymerase Chain ReactionPleural EffusionAnti-Bacterial AgentsCommunity-Acquired InfectionsHumansMaleFemaleChild, PreschoolChildInfantMethicillin-Resistant Staphylococcus aureusPneumonia, PneumococcalCohort StudiesColoradoAdolescent

Stichwörter der Autor:innen

Streptococcus pneumoniaePCRchildrencomplicated pneumoniapleural fluid

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Section of Infectious Diseases and Epidemiology, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado, USA.
  • Department of Pathology and Laboratory Medicine, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.

ORCID-Profile: Erin C Ho

Förderung

  • Pediatric Infectious Diseases Society
  • Stanley and Susan Plotkin and
  • Sanofi Pasteur

Zitieren

APA

Ho, E. C., Olson, K. E., Butler, M., Birkholz, M., Miller, K., MacBrayne, C. E., Jung, S., Messacar, K., Asturias, E. J., & Dominguez, S. R. (2024). Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae439

Vancouver

Ho EC, Olson KE, Butler M, Birkholz M, Miller K, MacBrayne CE, et al. Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae439

BibTeX
@article{Ho2024,
  author = {Ho, Erin C and Olson, Kaitlin E and Butler, Molly and Birkholz, Meghan and Miller, Kristen and MacBrayne, Christine E and Jung, Sarah and Messacar, Kevin and Asturias, Edwin J and Dominguez, Samuel R},
  title = {Clinical Impact of Pleural Fluid Streptococcus pneumoniae Polymerase Chain Reaction Testing in Children With Complicated Pneumonia},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae439}
}
Kostenlos starten →